Skip to content
10-Q

Quarterly Report

Bristol-Myers Squibb Company BMY CELG-RI

0000014272-26-000010

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 21, 2026 2.04B sh
Shares Diluted Q1 2026 · Mar 31, 2026 2.05B sh
Shares Diluted Q1 2026 · Mar 31, 2025 2.04B sh
Dividends Paid Q1 2026 · Mar 31, 2026 $1.28B
Dividends Paid Q1 2026 · Mar 31, 2025 $1.26B
Capex Q1 2026 · Mar 31, 2026 $347M
Capex Q1 2026 · Mar 31, 2025 $260M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $1.1B
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.95B
Long Term Debt Q1 2026 · Mar 31, 2026 $42.15B
Long Term Debt Q1 2026 · Dec 31, 2025 $42.85B
Short Term Debt Q1 2026 · Mar 31, 2026 $2.31B
Short Term Debt Q1 2026 · Dec 31, 2025 $2.26B
Cash And Equivalents Q1 2026 · Mar 31, 2026 $9.57B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $10.21B
Stockholders Equity Q1 2026 · Mar 31, 2026 $20.07B
Stockholders Equity Q1 2026 · Dec 31, 2025 $18.47B
Current Liabilities Q1 2026 · Mar 31, 2026 $19.16B
Current Liabilities Q1 2026 · Dec 31, 2025 $23.42B
Total Liabilities Q1 2026 · Mar 31, 2026 $66.37B
Total Liabilities Q1 2026 · Dec 31, 2025 $71.53B
Current Assets Q1 2026 · Mar 31, 2026 $27.21B
Current Assets Q1 2026 · Dec 31, 2025 $29.39B
Total Assets Q1 2026 · Mar 31, 2026 $86.48B
Total Assets Q1 2026 · Dec 31, 2025 $90.04B
Eps Diluted Q1 2026 · Mar 31, 2026 $1.31
Eps Diluted Q1 2026 · Mar 31, 2025 $1.20
Eps Basic Q1 2026 · Mar 31, 2026 $1.31
Eps Basic Q1 2026 · Mar 31, 2025 $1.21
Sga Expense Q1 2026 · Mar 31, 2026 $1.62B
Sga Expense Q1 2026 · Mar 31, 2025 $1.58B
Rd Expense Q1 2026 · Mar 31, 2026 $2.65B
Rd Expense Q1 2026 · Mar 31, 2025 $2.26B
Net Income Q1 2026 · Mar 31, 2026 $2.68B
Net Income Q1 2026 · Mar 31, 2025 $2.46B
Cost Of Revenue Q1 2026 · Mar 31, 2026 $3.42B
Cost Of Revenue Q1 2026 · Mar 31, 2025 $3.03B
Revenue Q1 2026 · Mar 31, 2026 $11.49B
Revenue Q1 2026 · Mar 31, 2025 $11.2B